| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Alvaro Alonso | Q39964242 |
| Eleni Linos | Q40458161 | ||
| Tim Raine | Q60656167 | ||
| P2093 | author name string | Dominique Michaud | |
| P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
| Meta-analysis in clinical trials | Q27860779 | ||
| Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
| History of allergic disease and risk of meningioma | Q34593492 | ||
| All in the head: obstacles for immune rejection of brain tumours | Q34842204 | ||
| Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk | Q35170472 | ||
| Polymorphisms associated with asthma are inversely related to glioblastoma multiforme | Q35570946 | ||
| Inhibition of angiogenesis by interleukin 4. | Q36401812 | ||
| Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma | Q37360189 | ||
| History of allergies and risk of glioma in adults. | Q40475089 | ||
| History of allergies among adults with glioma and controls | Q40650061 | ||
| Divergent responses of human astrocytoma and non-neoplastic astrocytes to tumor necrosis factor alpha involve the 55 kDa tumor necrosis factor receptor | Q41570987 | ||
| Medical risk factors and the development of brain tumors | Q41848749 | ||
| Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma | Q42631907 | ||
| Reduced immunoglobulin E and allergy among adults with glioma compared with controls | Q43634931 | ||
| Gene therapy of experimental brain tumors using neural progenitor cells | Q44761775 | ||
| Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells | Q45879265 | ||
| Role of medical history in brain tumour development. Results from the international adult brain tumour study | Q48173274 | ||
| The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis | Q48605963 | ||
| History of allergies and autoimmune diseases and risk of brain tumors in adults | Q48620344 | ||
| Association of adult glioma with medical conditions, family and reproductive history | Q48729675 | ||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| meta-analysis | Q815382 | ||
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1544-1550 | |
| P577 | publication date | 2007-10-09 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Atopy and risk of brain tumors: a meta-analysis | |
| P478 | volume | 99 |
| Q37524853 | A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: an exploratory case-only study |
| Q28395481 | A pooled multisite analysis of the effects of atopic medical conditions in glioma risk in different ethnic groups |
| Q55456781 | Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014. |
| Q64060058 | Allergic Signs in Glioma Pathology: Current Knowledge and Future Perspectives |
| Q55457496 | Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study. |
| Q38402068 | Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects |
| Q92546031 | Allergies and Asthma in Relation to Cancer Risk |
| Q42954516 | Allergies and adult gliomas: cohort results strengthen evidence for a causal association |
| Q36687544 | Allergies and risk of head and neck cancer |
| Q34577067 | Allergies and risk of head and neck cancer: an original study plus meta-analysis |
| Q37127919 | Allergies and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium |
| Q34394208 | AllergoOncology: the role of IgE-mediated allergy in cancer |
| Q58260286 | Allergy |
| Q40256164 | Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand |
| Q48185601 | Allergy and glioma risk: test of association by genotype. |
| Q34132833 | Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastoma |
| Q40350895 | Allergy and risk of glioma: a meta-analysis |
| Q61453333 | Allergy may confer better survival on patients with gliomas |
| Q30365873 | Allergy reduces the risk of meningioma: a meta-analysis |
| Q34149065 | An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients |
| Q28388251 | Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system |
| Q35202223 | Anthropometric measures, physical activity, and risk of glioma and meningioma in a large prospective cohort study |
| Q55461495 | Antihistamine use and immunoglobulin E levels in glioma risk and prognosis. |
| Q36921260 | Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study |
| Q34802578 | Assessment of type of allergy and antihistamine use in the development of glioma |
| Q37238868 | Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls |
| Q37641243 | Association between leukocyte telomere length and glioma risk: a case-control study |
| Q37366033 | Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1. |
| Q33956554 | Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking |
| Q43482439 | Asthma and risk of brain cancer in children |
| Q45278583 | Atopic conditions and brain tumor risk in children and adolescents--an international case-control study (CEFALO). |
| Q91846463 | Autoimmune diseases and immunosuppressive therapy in relation to the risk of glioma |
| Q30481789 | Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium |
| Q51482870 | Cancer risk in patients with allergic rhinitis, asthma and atopic dermatitis: a nationwide cohort study in Taiwan. |
| Q92446802 | Case-Based Review: newly diagnosed glioblastoma |
| Q35920687 | Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma |
| Q23919640 | Common variation in genes related to innate immunity and risk of adult glioma |
| Q41389046 | Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma |
| Q38218302 | Cytomegalovirus and glioma: putting the cart before the horse |
| Q26996612 | Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options |
| Q28389459 | Early life exposures and the risk of adult glioma |
| Q37925037 | Eczema and cancer risk: a critical appraisal and review of the literature |
| Q97543137 | Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma |
| Q55460610 | Eosinophil infiltrates in pilocytic astrocytomas of children and young adults. |
| Q35717319 | Eosinophils in glioblastoma biology |
| Q34154936 | Epidemiology and etiology of meningioma |
| Q51152506 | Epidemiology of glioblastoma |
| Q37969919 | Epidemiology: allergy history, IgE, and cancer |
| Q29248257 | Evidence from a large-scale meta-analysis indicates eczema reduces the incidence of glioma |
| Q38131489 | Exploitation of adaptive evolution in glioma treatment |
| Q33950535 | Exploring the association between melanoma and glioma risks |
| Q35118946 | GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation |
| Q28396146 | Genetic advances in glioma: susceptibility genes and networks |
| Q92948858 | Genetic and molecular epidemiology of adult diffuse glioma |
| Q34132866 | Genetic variants in inflammation pathway genes and asthma in glioma susceptibility |
| Q39152200 | Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment |
| Q46820292 | Glioma. |
| Q36089655 | HMG CoA reductase inhibitors, NSAIDs and risk of glioma |
| Q77790317 | High parental occupational social contact and risk of childhood hematopoietic, brain and bone cancers |
| Q40449390 | Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas |
| Q40388239 | History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). |
| Q35136924 | Human immunoglobulin G levels of viruses and associated glioma risk |
| Q33818269 | IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. |
| Q26866513 | Immunotherapy advances for glioblastoma |
| Q34701587 | Immunotherapy of brain cancers: the past, the present, and future directions |
| Q37608106 | Immunotherapy of pediatric brain tumor patients should include an immunoprevention strategy: a medical hypothesis paper |
| Q52655627 | Impact of atopy on risk of glioma: a Mendelian randomisation study. |
| Q34102061 | Impact of single nucleotide polymorphism in IL-4, IL-4R genes and systemic concentration of IL-4 on the incidence of glioma in Iraqi patients |
| Q33903717 | Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth |
| Q30414501 | Inflammation and Gliomagenesis: Bi-Directional Communication at Early and Late Stages of Tumor Progression |
| Q28383820 | Inherited variation in immune genes and pathways and glioblastoma risk |
| Q35967977 | Inhibition of tumor progression during allergic airway inflammation in a murine model: significant role of TGF-β. |
| Q28397886 | Integration of epidemiology, immunobiology, and translational research for brain tumors |
| Q37633252 | Interaction of allergy history and antibodies to specific varicella-zoster virus proteins on glioma risk |
| Q33944411 | Inverse association between eczema and meningioma: a meta-analysis |
| Q36089397 | Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival |
| Q23917504 | Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk |
| Q26744387 | Malignant gliomas: old and new systemic treatment approaches |
| Q37533615 | Molecular epidemiology of primary brain tumors |
| Q30383807 | Nervous System and Intracranial Tumour Incidence by Ethnicity in England, 2001-2007: A Descriptive Epidemiological Study. |
| Q49098244 | Non-steroidal anti-inflammatory drug use and brain tumour risk: a case-control study within the Clinical Practice Research Datalink |
| Q44633796 | Nonallergic comorbidities of atopic dermatitis |
| Q27023002 | Nonallergic comorbidities of atopic eczema: an overview of systematic reviews |
| Q36071664 | Nonsteroidal anti-inflammatory drugs and glioma in the NIH-AARP Diet and Health Study cohort |
| Q35762521 | Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis |
| Q36803476 | Pediatric gliomas as neurodevelopmental disorders |
| Q35486851 | Polymorphisms in IL-4/IL-13 pathway genes and glioma risk: an updated meta-analysis |
| Q35499988 | Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies |
| Q41472948 | Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. |
| Q49093554 | Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort |
| Q35916610 | Reduced allergy and immunoglobulin E among adults with intracranial meningioma compared to controls |
| Q38020690 | Relationship between allergy and cancer: an overview |
| Q23910577 | Risk factors for oligodendroglial tumors: a pooled international study |
| Q24601105 | Risk of meningioma and common variation in genes related to innate immunity |
| Q37328326 | Role of inflammation and oxidative stress mediators in gliomas |
| Q33965744 | Season of birth and risk for adult onset glioma |
| Q57287645 | Serially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel |
| Q35772513 | Serum macrophage-derived chemokine/CCL22 levels are associated with glioma risk, CD4 T cell lymphopenia and survival time |
| Q28384239 | Single-nucleotide polymorphisms of allergy-related genes and risk of adult glioma |
| Q46227922 | Socioeconomic status and glioblastoma risk: a population-based analysis |
| Q41865517 | Solasonine inhibits glioma growth through anti-inflammatory pathways |
| Q63966081 | Survival of glioma patients in relation to mobile phone use in Denmark, Finland and Sweden |
| Q60917015 | Targeting Telomerase and ATRX/DAXX Inducing Tumor Senescence and Apoptosis in the Malignant Glioma |
| Q30397712 | Temporal bone meningioma involving the middle ear: A case report |
| Q47755845 | The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) Resource in Neuro-Oncology |
| Q28387839 | The epidemiology of glioma in adults: a "state of the science" review |
| Q38211074 | The role of inflammation in brain cancer |
| Q48310212 | Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010. |
| Q59329465 | Use of Mendelian andomization for dentifying isk actors for rain umors |
| Q98499768 | Vesiclemia: counting on extracellular vesicles for glioblastoma patients |
Search more.